Edward Morrow Atkinson III - 17 Feb 2022 Form 3 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, Attorney-in-Fact for Edward Morrow Atkinson III
Issuer symbol
ETNB
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
3
Filing time
01 Mar 2022, 17:39:05 UTC
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETNB Stock Option (Right to Buy) 17 Feb 2022 Common Stock 30,000 $4.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, which will vest in equal installments on February 17, 2023, February 17, 2024 and February 17, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney